Pfizer, Sanofi, to boost South African Biovac's vaccine output
South Africa's Biovac Institute will start local production of Sanofi's Hexaxim vaccine next year and Pfizer's anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: African Health | Health | Pfizer | Pneomococcal Vaccine | Pneumonia | South Africa Health | Vaccines